Phase-III study of a novel hypoglycemic agent, AY4166, on NIDDM patients in Japan (2) : Placebo-controlled multicenter double-bind study

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1572261550162749440
  • NII Article ID
    10016607286
  • Data Source
    • CiNii Articles

Report a problem

Back to top